
Last night, as dozens of biotech companies rushed to issue stock following the massive spike in Moderna shares on some extremely preliminary trial results inspired the biggest short-squeeze in US equities since the beginning of May, we warned that Moderna shareholders might be in for a bruising “bait-and-switch” as reports about insider share sales emerged, and Moderna, along…
White House Vaccine Czar Sells $12 Million Slug Of Moderna Options For Massive Profit — geopolitic




